Navigation Links
Key Trigger Of Opioid Withdrawal Symptoms Found

Researchers have discovered an important chemical in the brain's neuronal machinery that triggers some of the withdrawal symptoms of opioid drugs like morphine and heroin.

They believe that drugs to inhibit the chemical--called a transporter--could relieve some of the early physical symptoms of withdrawal, such as teeth-chattering, uncontrolled shaking, and jumpiness. Such drugs could become part of the arsenal of medicines and behavioral techniques aimed at helping addicts kick their habits.


To zero in on the machinery underlying withdrawal symptoms, researchers led by Elena Bagley and Macdonald Christie of the Pain Management Research Institute at Royal North Shore Hospital (a division of the University of Sydney) performed biochemical studies on brain slices from mice that had been treated with morphine. Their objective was to understand what happens to a particular region of the midbrain--called the periaqueductal gray (PAG)--known to be involved in such withdrawal symptoms. Opiate addiction inhibits neuron activity in this region, which alters the neuronal machinery to compensate for this inhibition. Upon opiate withdrawal, the neurons rebound, becoming hyperactive.

The scientists' analysis revealed that a transporter molecule for the neurotransmitter GABA was responsible for the electrical abnormalities that produce a hyperexcitability in the neurons. Neurotransmitters are the molecular ammunition that one neuron fires at its neighbor to trigger a nerve impulse in the neighbor. Propagation of such nerve impulses through the networks of neurons in the brain is the basis of all neural activity. Transporter molecules are the proteins that retrieve neurotransmitter molecules from the spaces between neurons after they trigger nerve impulse, to reload the neuron for its next signaling burst.

Bagley and her colleagues also discovered that a molecular switch called protein kinase A was part of the triggering machinery involved in activating the abnormal GABA transporter activity.

Importantly, the researchers found that drugs that inhibit either the GABA transporter activity or protein kinase A eliminate the hyperexcitability of the PAG neurons in the mouse brain slices.

The researchers cited other studies showing that treatment with opioids also altered levels of the transporter for the neurotransmitter glutamate, "suggesting that neurotransmitter transporters may prove to be useful targets for management of opioid dependence," they wrote. The researchers also wrote that, since GABA is a neurotransmitter that inhibits nerve impulses, drugs to inhibit the GABA transporter "could produce their therapeutic effect through altering extracellular GABA concentrations as well as directly altering the excitability of GABAergic neurons."

###

Elena E. Bagley, Michelle B. Gerke, Christopher W. Vaughan, Stephen P. Hack, and MacDonald J. Christie: "GABA Transporter Currents Activated by Protein Kinase A Excite Midbrain Neurons during Opioid Withdrawal"

Publishing in Neuron, Volume 45, Number 3, February 3, 2005, pages 433?45. http://www.neuron.org


'"/>

Source:Cell Press


Related biology news :

1. Bacteria in Household Dust May Trigger Asthma Symptoms
2. Opiates Better Than Sedatives For Treating Newborns In Withdrawal
3. Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy
4. Synthetic Protein Eases Arthritis Symptoms in Mice
5. Potential Drug Target For Treating Cocaine Abuse Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... March 21, 2017 ... ... regional blood flow and tissue oxygenation, is being explored as a way to track ... near-infrared spectroscopy study on tonic pain activation by cold pressor test ,” published today ...
(Date:3/22/2017)... and PETACH TIKVAH, Israel , ... BCLI), a leading developer of adult stem cell technologies ... , Chief Executive Officer, will provide an update on ... 2 nd Annual Neuroscience Biopartnering and Investment Forum, ... New York Academy of Sciences. ...
(Date:3/22/2017)... , March 22, 2017   Invitae Corporation ... genetic information companies, today announced the availability of ... Spinal Muscular Atrophy (SMA) , a neuromuscular ... genetic disorders among infants as well as a ... The new test, announced during the American College ...
(Date:3/20/2017)... ... March 20, 2017 , ... HOLLOWAY ... companies, recently announced it will debut a brand new pressure vessel, the intelliVessel™, ... is controlled by a touch screen panel and features other revolutionary operations that ...
Breaking Biology Technology: